Microsoft Word - DUR Committee Oct Agenda2.doc - Niacin simvastatin - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-10-08 09:02:37 Combination drugs Nootropics Schering-Plough Merck Organofluorides Dexmethylphenidate Sitagliptin/metformin Certolizumab pegol Niacin/simvastatin Pharmacology Chemistry Medicine		Microsoft Word - DUR Committee Oct Agenda2.doc Add to Reading List Source URL: www.mainecarepdl.org Download Document from Source Website File Size: 21,20 KB Share Document on Facebook

	niaspan [removed]niaspan DocID: NLMD - View Document
	Niacin ER/Simvastatin (ABT-118) M10-013 Clinical Study Report - SUPREME R&D[removed] DocID: JSFw - View Document
	March 2012 Michael Cobble, MD Chief Medical Officer Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. Christie Ballantyne, MD, et al. J DocID: IA2t - View Document
	Microsoft Word - DUR Committee Oct Agenda2.doc DocID: HpCt - View Document
	Microsoft PowerPoint - FINAL_Merck_Strung.ppt DocID: GtAM - View Document